Phase II Study of Range and Schedule of rPA Doses

NCT00170456 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

415

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention of Bacillus Anthracis (Anthrax) Infection

Interventions

BIOLOGICAL: rPA vaccine containing alhydrogel

Sponsor

PharmAthene UK Limited

Collaborators

[object Object]